Phase 1a study of first hormonefree male pill completes enrollmentDURHAM, NC / ACCESSWIRE / March 27, 2024 / Male Contraceptive Initiative has invested $500,000 in YourChoice Therapeutics, a San Francisco biotech startup, developing the first hormonefree male birth control pill. YCT529s firstinhuman study is fully enrolled and represents a milestone in advancing reproductive health equity for men... Lire le communiqué |